Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model.
Matossian MD, Burks HE, Elliott S, Hoang VT, Bowles AC, Sabol RA, Wahba B, Anbalagan M, Rowan B, Abazeed ME, Bunnell BA, Moroz K, Miele L, Rhodes LV, Jones SD, Martin EC, Collins-Burow BM, Burow ME.
Matossian MD, et al.
BMC Cancer. 2019 Mar 7;19(1):205. doi: 10.1186/s12885-019-5401-2.
BMC Cancer. 2019.
PMID: 30845999
Free PMC article.